The Cigna Group (CI)
Health Care3 articles
Price chart
The Cigna Group (CI) overview
The Cigna Group is a major U.S. health-insurance and pharmacy-benefits company. It is a member of the S&P 500 and is classified in the Health Care sector — pharmaceutical, biotech, device and managed-care companies.
The Cigna Group trades on the NYSE under the ticker symbol CI. As of the most recent market data, the stock was priced around $281.45, down 0.84% on the session, giving The Cigna Group a market capitalization of roughly $74.45B.
Over the past 52 weeks, CI has traded between $239.51 and $315.47. Shares are valued at a trailing price-to-earnings (P/E) ratio of about 11.9, a common gauge of how richly the market prices the company's earnings. The Cigna Group also pays a dividend, currently yielding around 2.20%.
Key statistics
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Why investors watch CI
As one of the larger companies in the Health Care sector, The Cigna Group is closely followed by investors and often moves with broader trends across pharmaceutical, biotech, device and managed-care companies. Traders watch CI for earnings reports, analyst rating changes, and headlines that can shift sentiment — each of which is summarized on this page as it breaks.
Market Mood
Latest CI news
Cigna Group (CI) Form 144 Filed on June 12 for Shares
On June 12, Cigna Group (CI) filed a Form 144, which indicates potential plans for the sale of shares. Form 144 is typically filed by affiliates or insiders to notify the SEC of a proposed sale of restricted or control securities. This filing can signal changes in ownership and may affect investor confidence. It’s important for stakeholders to monitor these filings as they can have implications for stock liquidity and future volatility.
Read More: Cigna Group (CI) Form 144 Filed on June 12 for Shares
Cigna (CI) Downgraded by Barclays, Price Target Cut to $304
On May 26, Barclays downgraded Cigna (CI) from Overweight to Equal Weight and reduced its price target from $310 to $304. The downgrade reflects concerns around Cigna's limited earnings upside potential due to its lower exposure to government insurance programs, alongside uncertainties regarding a pharmacy benefit manager transition. Additionally, Barclays highlighted risks related to commercial membership losses and potential job cuts related to AI. This situation contrasts with UBS's recent rating increase, raising Cigna's target to $400, indicating differing outlooks among analysts.
Read More: Cigna (CI) Downgraded by Barclays, Price Target Cut to $304
Cigna (CI) Q1 2026 Earnings Beat Expectations; Raises EPS Guidance
Cigna (CI) reported its Q1 2026 earnings, exceeding analyst expectations. The company raised its earnings per share (EPS) guidance for the year, indicating stronger financial performance. Cigna's revenue figures and additional growth metrics contributed to the positive outlook, which may influence investor sentiment and market performance. The upward revision of EPS guidance is particularly significant for forecasting future profitability and competitive positioning in the market.
Read More: Cigna (CI) Q1 2026 Earnings Beat Expectations; Raises EPS GuidanceMore Health Care stocks
Frequently asked questions
Is The Cigna Group in the S&P 500?
Yes. The Cigna Group (CI) is a member of the S&P 500 index, classified in the Health Care sector.
What sector is CI in?
The Cigna Group is classified in the Health Care sector of the S&P 500 — pharmaceutical, biotech, device and managed-care companies.
Where can I find the latest CI news?
This page collects recent The Cigna Group (CI) news and market analysis, each article summarized by AI and tagged with bullish, bearish, or neutral sentiment.
What is The Cigna Group's stock price?
As of the most recent market data, The Cigna Group (CI) traded at approximately $281.45. Prices move throughout the trading day, so this reflects the latest available quote rather than a live price.
What is The Cigna Group's market cap?
The Cigna Group has a market capitalization of roughly $74.45B, based on its most recent share price and shares outstanding.
What is CI's P/E ratio?
CI trades at a trailing price-to-earnings ratio of about 11.9. The P/E ratio compares a company's share price to its earnings per share.